CytoDyn Inc.
CYDY
$0.2926
-$0.0034-1.15%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.18% | 0.21% | -124.80% | 214.54% | -40.83% |
| Total Depreciation and Amortization | -20.00% | 25.00% | -20.00% | 25.00% | -42.86% |
| Total Amortization of Deferred Charges | -46.36% | -2.65% | -9.60% | 0.00% | -79.58% |
| Total Other Non-Cash Items | 4,507.69% | -97.16% | -78.92% | -77.58% | 43.68% |
| Change in Net Operating Assets | -13.19% | -153.62% | 103.78% | -401.33% | 138.73% |
| Cash from Operations | -14.27% | -38.20% | -165.92% | 429.70% | 29.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 5,452.38% | -- | -- | -- | 28.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | 5,452.38% | -- | -100.00% | 180.94% | -5.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.88% | -37.62% | -123.74% | 743.50% | 37.88% |